Gregory D Rak (Gregory Rak)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Induced Pluripotent Stem Cells

Transforming Growth Factor

Top Venues

Journal of applied toxicology : JAT

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Kent Thudium, Mark Selby, Julie A Zorn, Gregory D Rak, Xi-Tao Wang, Roderick Todd Bunch, Jason M Hogan, Pavel Strop, Alan J Korman
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab. Cancer immunology research 10 (10) (2022)
Gregory D Rak, Melvin R White, Karen Augustine-Rauch, Courtni Newsome, Michael J Graziano, Gene E Schulze
Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS-986260, mitigates class-based cardiovascular toxicity in dogs but not rats. Journal of applied toxicology : JAT 40 (7) (2020)